Responses
Poster Presentation
Rheumatoid arthritis - prognosis, predictors and outcome
THU0160 The Effect of VX-509, a Selective Oral Jak3 Inhibitor, on Plasma Biomarkers of Disease Activity in Patients with Rheumatoid Arthritis
Compose a Response to This Article
Other responses
No responses have been published for this article.